VWWMG
GILD icon

Vermillion & White Wealth Management Group’s Gilead Sciences GILD Stock Holding History

Vermillion & White Wealth Management Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-204
Closed -$25K – 242
2025
Q4 		$25K Buy
204
+85
+71% +$10.3K 0.01% 229
2025
Q3 		$13.2K Buy
119
+49
+70% +$5.57K 0.01% 297
2025
Q2 		$7.76K Hold
70
– – 0.01% 327
2025
Q1 		$7.84K Hold
70
– – 0.01% 304
2024
Q4 		$6.47K Hold
70
– – ﹤0.01% 257
2024
Q3 		$5.87K Hold
70
– – ﹤0.01% 247
2024
Q2 		$4.8K Hold
70
– – ﹤0.01% 270
2024
Q1 		$5.13K Hold
70
– – ﹤0.01% 248
2023
Q4 		$5.67K Buy
+70
New +$5.45K 0.01% 199

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vermillion & White Wealth Management Group's GILD Position: Q1 2026 in Review

Vermillion & White Wealth Management Group sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 204 shares — an estimated $25K sold.

Vermillion & White Wealth Management Group first reported a position in GILD in Q4 2023 and held it in 9 quarters. The position peaked at $25K in Q4 2025. 2,326 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Vermillion & White Wealth Management Group reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
  • Vermillion & White Wealth Management Group sold 204 Gilead Sciences shares in Q1 2026, an estimated $25K.
  • Vermillion & White Wealth Management Group first reported a position in Gilead Sciences in Q4 2023 and held it in 9 quarters.
  • Vermillion & White Wealth Management Group's Gilead Sciences position peaked at $25K in Q4 2025.
  • 2,326 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Vermillion & White Wealth Management Group's 13F filing for Q1 2026, filed 14 May 2026.